Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/13/20 | Others | Director | 109,372 | 0.1671% | ||
| 10/13/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/10/20 | Tender | General Counsel | 391,686 | 0.5984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| +3.31% | -3.70% | +61.03% | +103.64% | 70.42B | |
| +0.69% | +2.12% | +48.78% | +92.50% | 65.4B | |
| -1.31% | -0.50% | +7.41% | -4.29% | 28.28B | |
| -0.69% | +1.73% | +59.01% | +11.60% | 26.57B | |
| +0.40% | -4.80% | -5.89% | +469.55% | 27.16B | |
| 0.00% | +0.89% | +36.11% | -17.87% | 20.09B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 20.61B | |
| +1.63% | -0.75% | +14.16% | +549.08% | 15.87B | |
| -1.09% | +3.14% | +46.32% | +155.12% | 13.9B | |
| Average | +0.40% | +1.16% | +59.60% | +197.74% | 32.03B | |
| Weighted average by Cap. | +0.94% | +0.72% | +56.37% | +157.70% |
Employees
-
